Abstract
ObjectivesTo assess benefits and harms arising from increasing gestational diabetes (GDM) diagnosis, including for women with normal-sized babies.Design, setting and participantsDiagnosis rates, outcomes, interventions and medication use are compared in a retrospective cohort study of 229 757 women birthing in public hospitals of the Australian State of Queensland during two periods, 2011–2013 and 2016–2018, using data from the Queensland Perinatal Data Collection.Outcome measuresComparisons include hypertensive disorders, caesarean section, shoulder dystocia and associated harm, induction of labour (IOL), planned birth (PB), early planned birth <39 weeks (EPB), spontaneous labour onset with vaginal birth (SLVB) and medication use.ResultsGDM diagnosis increased from 7.8% to 14.3%. There was no improvement in shoulder dystocia associated injuries, hypertensive disorders or caesarean sections. There was an increase in IOL (21.8%–30.0%; p<0.001), PB (36.3% to 46.0%; p<0.001) and EPB (13.5%–20.6%; p<0.001), and a decrease in SLVB (56.0%–47.3%; p<0.001). Women with GDM experienced an increase in IOL (40.9%–49.8%; p<0.001), PB (62.9% to 71.8%; p<0.001) and EPB (35.3%–45.7%; p<0.001), and a decrease in SLVB (30.01%–23.6%; p<0.001), with similar changes for mothers with normal-sized babies. Of women prescribed insulin in 2016–2018, 60.4% experienced IOL, 88.5% PB, 76.4% EPB and 8.0% SLVB. Medication use increased from 41.2% to 49.4% in women with GDM, from 3.2% to 7.1% in the antenatal population overall, from 3.3% to 7.5% in women with normal-sized babies and from 2.21% to 4.38% with babies less than the 10th percentile.ConclusionOutcomes were not apparently improved with increased GDM diagnosis. The merits of increased IOL or decreased SLVB depend on the views of individual women, but categorising more pregnancies as abnormal, and exposing more babies to the potential effects of early birth, medication effects and growth limitation may be harmful.
Funder
Toowoomba Hospital Foundation
Reference92 articles.
1. Australian Institute of Health and Welfare . Incidence of gestational diabetes in Australia. Cat. no. CVD 85. Canberra: AIHW, 2019. Available: https://www.aihw.gov.au/reports/diabetes/incidence-of-gestational-diabetes-in-australia
2. Gestational diabetes mellitus ‐ management guidelines: the Australasian diabetes in pregnancy Society;Hoffman;Medical Journal of Australia,1998
3. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
4. World Health Organization . Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. In: World health Organization. 2013. Available: https:apps.who.int/iris/handle/10665/85975
5. Nankervis A , McIntyre HD , Moses R . Ross GP et al for the Australasian diabetes in pregnancy Society. In: ADIPS Consensus Guidelines for the Testing and Diagnosis of Gestational Diabetes mellitus in Australia. 2014.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献